Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://virogin.com/sitemap_index.xml # --------------------------- # END YOAST |
Title | Virogin |
Description | Next-Generation Oncolytic Creating impactful drugs for patients with the highest medical need. At Virogin, we are at the forefront of developing novel oncolytic |
Keywords | N/A |
WebSite | virogin.com |
Host IP | 198.185.159.144 |
Location | United States |
Site | Rank |
US$3,258,765
Last updated: 2023-05-09 20:27:09
virogin.com has Semrush global rank of 3,247,950. virogin.com has an estimated worth of US$ 3,258,765, based on its estimated Ads revenue. virogin.com receives approximately 376,012 unique visitors each day. Its web server is located in United States, with IP address 198.185.159.144. According to SiteAdvisor, virogin.com is safe to visit. |
Purchase/Sale Value | US$3,258,765 |
Daily Ads Revenue | US$3,009 |
Monthly Ads Revenue | US$90,243 |
Yearly Ads Revenue | US$1,082,913 |
Daily Unique Visitors | 25,068 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
virogin.com. | A | 1798 | IP: 198.185.159.144 |
virogin.com. | A | 1798 | IP: 198.49.23.145 |
virogin.com. | A | 1798 | IP: 198.49.23.144 |
virogin.com. | A | 1798 | IP: 198.185.159.145 |
virogin.com. | NS | 1800 | NS Record: dns1.registrar-servers.com. |
virogin.com. | NS | 1800 | NS Record: dns2.registrar-servers.com. |
virogin.com. | MX | 1799 | MX Record: 0 virogin-com.mail.protection.outlook.com. |
virogin.com. | TXT | 1799 | TXT Record: v=spf1 ip4:173.254.192.99 include:spf.protection.outlook.com ~all |
CONTACT About History Our Leadership Team Scientific Advisory Board Technology Oncolytic Virotherapy Prime-Boost Approach Pipeline Clinical Trials Careers Investors Media Menu About History Our Leadership Team Scientific Advisory Board Technology Oncolytic Virotherapy Prime-Boost Approach Pipeline Clinical Trials Careers Investors Media About History Our Leadership Team Scientific Advisory Board Technology Oncolytic Virotherapy Prime-Boost Approach Pipeline Clinical Trials Careers Investors Media Menu About History Our Leadership Team Scientific Advisory Board Technology Oncolytic Virotherapy Prime-Boost Approach Pipeline Clinical Trials Careers Investors Media CONTACT Next-Generation Oncolytic Virotherapies Creating impactful drugs for patients with the highest medical need. LEARN MORE Virogin has developed an oncolytic HSV-1 platform capable of triggering long-lasting anti-tumor activity that leads to systemic cancer immunity. Oncolytic virotherapy is among the most promising agents |
HTTP/1.1 301 Moved Permanently Age: 125929 Date: Sun, 31 Oct 2021 00:53:43 GMT Location: https://virogin.com/ Server: Squarespace Set-Cookie: crumb=Bb+YRgzo1HgfODc3OGFlNzVmNjM3ZmQxZTcyNDI4MmJiNDYxYjU2;Path=/ X-Contextid: pnwyr614/MSoHE5cM HTTP/2 200 accept-ranges: bytes age: 215083 content-type: text/html;charset=utf-8 date: Sat, 30 Oct 2021 00:07:49 GMT etag: W/"0811e7daebb5c6bec6970bedf565639f--gzip" expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=Bad+ai5b43/lNTc1ZjFiYWNhNDcxYzMwOTllYjYzNWNjMjAzZGYy;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: bPtdieTn/gbRxXvIo |
Domain Name: VIROGIN.COM Registry Domain ID: 1929677149_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.namecheap.com Registrar URL: http://www.namecheap.com Updated Date: 2021-05-08T21:28:54Z Creation Date: 2015-05-17T04:00:54Z Registry Expiry Date: 2022-05-17T04:00:54Z Registrar: NameCheap, Inc. Registrar IANA ID: 1068 Registrar Abuse Contact Email: abuse@namecheap.com Registrar Abuse Contact Phone: +1.6613102107 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.REGISTRAR-SERVERS.COM Name Server: DNS2.REGISTRAR-SERVERS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T20:55:01Z <<< |